Cargando…
Reviewing the Utility of EUS FNA to Advance Precision Medicine in Pancreatic Cancer
Advanced pancreatic cancer (PC) is an aggressive malignancy with few effective therapeutic options. While the evolution of precision medicine in recent decades has changed the treatment landscape in many cancers, at present no targeted therapies are used in the routine management of PC. Only a minor...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836067/ https://www.ncbi.nlm.nih.gov/pubmed/29382047 http://dx.doi.org/10.3390/cancers10020035 |